FIBROGEN INC
Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.
FGEN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US31572Q8087
- LEI:
- Country:
- United States of America
- Address:
- 350 BAY STREET, 94133 SAN FRANCISCO
- Website:
- https://www.fibrogen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
FibroGen, Inc. is a biopharmaceutical company that discovers, develops, and commercializes a pipeline of first-in-class therapeutics. The company is dedicated to creating innovative treatments for serious unmet medical needs, particularly chronic and life-threatening conditions. Its primary research and development efforts are focused on the frontiers of cancer biology and anemia, with key programs in areas such as pancreatic cancer. FibroGen aims to accelerate the delivery of novel therapies through its clinical trials and research initiatives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FIBROGEN INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FIBROGEN INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FIBROGEN INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
